Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Tocilizumab improves survival in COVID-19 patients with ARDS

The current COVID-19 pandemic caused by the SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2), has already nearly 4.8 million confirmed cases and more than 318,000 deaths.

18 May 2020

Chasing the elusive dream of a COVID cure

Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure for the disease that has killed nearly 260,000 people remains a long way off — and might never arrive.

15 May 2020

NIH begins clinical study to evaluate hydroxychloroquine and azithromycin for COVID-19

A clinical trial has begun to evaluate whether the malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent hospitalization and death from coronavirus disease 2019 (COVID-19).

14 May 2020

ACTG initiates clinical trial to evaluate treatment for COVID-19

The AIDS Clinical Trials Group, the world's largest and longest established HIV research network, today announced the initiation of ACTG 5395, a clinical trial to evaluate whether the drug combination hydroxychloroquine and azithromycin can prevent hospitalization and death from COVID-19 (which is caused by infection with the virus SARS-CoV-2).

14 May 2020

Anti-inflammatory drug may improve respiratory function in some severe COVID-19 cases

A small study in Greece found that the clinically approved anti-inflammatory drug anakinra, used to treat rheumatoid arthritis, improved respiratory function in patients with severe coronavirus disease 2019 (COVID-19).

14 May 2020

11 healthcare centers participate in clinical trial of Russian drug against novel coronavirus

Initially, the drug was developed to treat rheumatoid arthritis. BIOCAD developers receive regulatory authorization as part of the procedure approved by Decree No. 441 of the Government of the Russian Federation of April 4, 2020 since the mechanism of action of the active substance is associated with the cytokine storm, a life-threatening immune system response in patients with COVID-19.

14 May 2020

Study refutes link between anti-hormonal breast cancer therapy and rheumatoid arthritis risk

Breast cancer patients do not have an increased risk of developing rheumatoid arthritis. A Swedish cohort study has now come to this conclusion.

13 May 2020

Could JAK blockers help treat COVID-19?

A new study published in the journal Science Immunology in May 2020 reports that compounds that safely inhibit the JAK protein could be useful in treating COVID-19.

12 May 2020

A 'multi-omics' approach to the development of drugs against COVID-19

A new study published on the preprint server medRxiv* in May 2020 reports a multi-omics approach that could make it easier to develop drugs that are effective against COVID-19.

12 May 2020

Study reveals molecular mechanism of boswellic acid that plays key role in frankincense effect

Once upon a time, the Three Kings brought precious gifts to the new-born baby Jesus: as well as gold and myrrh, they also had frankincense in their bags.

12 May 2020

Study provides genetic explanation behind the sex bias observed in certain diseases

Some diseases exhibit a clear sex bias, occurring more often, hitting harder or eliciting different symptoms in men or women.

12 May 2020

Hydroxychloroquine is not effective against COVID-19, extensive U.S. study shows

Over the past few months, doctors resorted to repurposing medicines that have already been approved for other diseases to treat coronavirus patients. One drug that was widely used in the pandemic, hydroxychloroquine, has been found to be ineffective in treating the viral infection.

11 May 2020

Clinical trial launched to evaluate experimental COVID-19 therapies

Clinical leaders from the University of Kentucky's Markey Cancer Center, College of Medicine and College of Pharmacy have launched a clinical trial for experimental therapies to treat patients infected with COVID-19.

11 May 2020

Gum Health Day 2020 to be celebrated worldwide on 12 May

"Say NO to bleeding gums" is the slogan for Gum Health Day 2020, to be celebrated worldwide on 12 May. Its goal is to raise public awareness about bleeding gums, which are usually a sign of a gum disease that will require treatment at the dental practice.

11 May 2020

AI VIVO seeks pharma, biotech collaboration partners to advance drug candidates for COVID-19

AI VIVO has announced that it is seeking pharma and biotech collaboration partners to progress therapeutic candidates for COVID-19.

11 May 2020

NIH clinical trial evaluates antiviral plus anti-inflammatory drug for COVID-19

A randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen of the investigational antiviral remdesivir plus the anti-inflammatory drug baricitinib for coronavirus disease 2019 (COVID-19) has begun.

8 May 2020

Hydroxychloroquine shown to slow recovery for COVID-19 patients

As researchers try to piece together a therapeutic strategy against the ongoing COVID-19 pandemic, a recent retrospective study from Cleveland Clinic Abu Dhabi, assessed the Hydroxychloroquine's efficacy in increasing SARS-CoV-2 viral clearance, finding that it appeared to significantly slow viral clearance in mild to moderately ill COVID-19 patients.

5 May 2020

A new approach to prevent autoimmune diseases associated with aging

Prof. Viktor Seledtsov, a senior researcher at the IKBFU Center of Medical Biotechnologies and Alexei von Delwig, a researcher at Innovita Res (Vilnius, Lithuania) have published an article in Expert Review of Vaccines scientific journal.

4 May 2020

RA patients enrolled in Medicare plan face significant cost exposure on specialty drugs

After a sharp drop in out-of-pocket costs between 2010 and 2011, Medicare patients who use specialty biologic medications for rheumatoid arthritis have seen higher out-of-pocket spending for those same drugs because of gradual price increases, a new study in the Journal of the American Medical Association Open finds.

4 May 2020

Temple University Hospital is offering COVID-19 clinical trials, investigational treatments options

Temple University Hospital is now participating in a variety of clinical trials that are testing investigational treatment options for patients diagnosed with the novel coronavirus, or COVID-19.

30 Apr 2020

Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Tocilizumab improves survival in COVID-19 patients with ARDS

Chasing the elusive dream of a COVID cure

NIH begins clinical study to evaluate hydroxychloroquine and azithromycin for COVID-19

ACTG initiates clinical trial to evaluate treatment for COVID-19

Anti-inflammatory drug may improve respiratory function in some severe COVID-19 cases

11 healthcare centers participate in clinical trial of Russian drug against novel coronavirus

Study refutes link between anti-hormonal breast cancer therapy and rheumatoid arthritis risk

Could JAK blockers help treat COVID-19?

A 'multi-omics' approach to the development of drugs against COVID-19

Study reveals molecular mechanism of boswellic acid that plays key role in frankincense effect

Study provides genetic explanation behind the sex bias observed in certain diseases

Hydroxychloroquine is not effective against COVID-19, extensive U.S. study shows

Clinical trial launched to evaluate experimental COVID-19 therapies

Gum Health Day 2020 to be celebrated worldwide on 12 May

AI VIVO seeks pharma, biotech collaboration partners to advance drug candidates for COVID-19

NIH clinical trial evaluates antiviral plus anti-inflammatory drug for COVID-19

Hydroxychloroquine shown to slow recovery for COVID-19 patients

A new approach to prevent autoimmune diseases associated with aging

RA patients enrolled in Medicare plan face significant cost exposure on specialty drugs

Temple University Hospital is offering COVID-19 clinical trials, investigational treatments options

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in